|
FOR IMMEDIATE RELEASE CONTACT: Howard Clabo, FedEx, 901-434-7786 NFL.COM VOTERS SELECT Over 85,000 Votes Cast On NFL.com; Highest Vote Total Of The Season Quarterback CARSON PALMER of the Cincinnati Bengals and running back JULIUS JONES of the Dallas Cowboys are the FedEx Air & Ground NFL Players of the Week for games played on December 5-6, the NFL announced today. Palmer completed 29 of 36 passes for 382 yards and three touchdowns in the Bengals’ 27-26 victory over the AFC North-rival Baltimore Ravens. He recorded a passer rating of 127.1, connecting on touchdown passes of nine, 12 and 13 yards while leading the Bengals’ comeback from a 20-3 deficit. Jones ran for a career-high 198 yards and three touchdowns on 30 carries in the Cowboys’ 43-39 victory over the Seattle Seahawks. He scored on runs of eight and 10 yards and added a game-winning 17-yarder in the final minute. Palmer and Jones were selected from among finalists in the air and ground categories through 85,300 fan votes, the highest vote total of the 2004 season. The other FedEx Express NFL Player of the Week finalists were quarterbacks PEYTON MANNING of the Indianapolis Colts and DONOVAN MC NABB of the Philadelphia Eagles, while running backs KEVIN JONES of the Detroit Lions and CLINTON PORTIS of the Washington Redskins were the other finalists for FedEx Ground NFL Player of the Week. Fans voted for more than their favorite players. The weekly FedEx Air & Ground NFL Players of the Week Awards are also a win for the local community. Along with the player awards, FedEx is awarding Cincinnati Children's Hospital and Children’s Medical Center Dallas, the Children’s Hospital in each winning market, a check for $5,000. The children’s hospitals in the two season-long winner’s markets, announced at this year’s Super Bowl, will be awarded $25,000 each. That means that FedEx will deliver nearly $250,000 to local children’s hospitals around the country in recognition of the FedEx Air & Ground NFL Players of the Week Award winners. FedEx, the premier global provider of transportation, e-commerce and supply-chain management services, is the Official Delivery Service Sponsor of the NFL, Super Bowl and Pro Bowl. Through the weekly FedEx Air and Ground awards, FedEx recognizes those NFL players who represent the same speed, precision and teamwork that their customers have come to expect from the full range of FedEx air, ground, freight and international shipping services. 2004 FEDEX AIR & GROUND NFL PLAYERS OF THE WEEK
FOR IMMEDIATE RELEASE CONTACT: DAVE DECECCO, PEPSI-COLA, 914-253-2655 NFL.COM VOTERS SELECT STEELERS QB BEN ROETHLISBERGER Roethlisberger Wins Award for Eighth Time This Season More Than 124,000 Votes Cast On NFL.com; Highest Total of
the Season Voters on NFL.com have made their choice. Quarterback BEN ROETHLISBERGER of the Pittsburgh Steelers is the PEPSI NFL ROOKIE OF THE WEEK for games played on December 5-6, the NFL announced today. Roethlisberger threw for 221 yards and two touchdowns, completing 14 of 17 passes in the Steelers’ 17-16 victory over the Jacksonville Jaguars. Roethlisberger registered a 158.0 passer rating while improving to 10-0 as a starter. He added three carries for 40 yards. This is Roethlisberger’s eighth Pepsi NFL Rookie of the Week award. More than 124,000 fans voted this week on NFL.com, the highest vote total of the 2004 season. Roethlisberger was selected from among five finalists. The other finalists were wide receiver LEE EVANS of the Buffalo Bills, running back STEVEN JACKSON of the St. Louis Rams, running back JULIUS JONES of the Dallas Cowboys and running back KEVIN JONES of the Detroit Lions. After the regular season, five players will be nominated for Pepsi NFL Rookie of the Year honors. Fans can vote for the winner on NFL.com throughout the month of January. The winner will be announced at a press conference at Super Bowl XXXIX in Jacksonville. This is Pepsi’s third year as the official soft drink sponsor of the NFL. 2004 PEPSI NFL ROOKIE OF THE WEEK
Contact :Seth Rubin
Matt Hill
JULIUS
JONES’ GAME-WINNING TOUCHDOWN RUN NAMED NEW YORK—DECEMBER 9, 2004 – Dallas Cowboys rookie running back Julius Jones’ game-winning, 17-yard touchdown run against the Seattle Seahawks has been voted "LEVITRAâ (vardenafil HCI) PLAY OF THE WEEK" for NFL games played December 5-6.Jones’ game-winning run is now eligible to be selected as "LEVITRAâ PLAY OF THE YEAR," awarded this February at Super Bowl XXXIX in Jacksonville, Florida. "LEVITRAâ PLAY OF THE WEEK," which is voted on by fans each week throughout the NFL season from Tuesday at noon ET to Thursday at noon ET on NFL.com, is presented each Thursday and recognizes the single most exciting play that week. Fans who vote at NFL.com each week can also enter for their chance to win a three-day/two-night trip for two to Jacksonville, Florida to attend Super Bowl XXXIX on February 6, 2005, including round-trip airfare and hotel accommodations. With only 32 seconds remaining in the game and the Cowboys trailing the Seahawks by three, Jones burst through the line, juked a defender and sprinted to the endzone for the game-winning score. Jones helped the Cowboys to a 43-39 victory with 198 rushing yards and three touchdowns. Jones beat out Buffalo Bills defensive tackle Pat Williams’ 20-yard interception return for a touchdown against the Miami Dolphins in fan voting on NFL.com. For details and video of this week’s nominees and the results of fan voting, please visit www.NFL.com/playoftheweek In July 2003, Bayer Pharmaceutical Corporation (Bayer) &
GlaxoSmithKline(GSK), co-marketers of LEVITRA (vardenafil HCI), a
prescription medicine that is used to treat erectile dysfunction (ED),
announced their groundbreaking sponsorship of the NFL. 2004 LEVITRAâ PLAY OF THE WEEK Winners
About LEVITRA LEVITRA is a prescription medicine that is used to treat erectile dysfunction (ED). Men taking nitrate drugs, often used to control chest pain (also known as angina), should not take LEVITRA. Men who use alpha blockers, sometimes prescribed for high blood pressure or prostate problems, also should not take LEVITRA. Such combinations could cause blood pressure to drop to an unsafe level. You should not take LEVITRA if your doctor determines that sexual activity poses a health risk for you. Men who experience an erection for more than four hours should seek immediate medical attention. LEVITRA does not protect against sexually transmitted diseases .The starting dose of LEVITRA is 10 mg taken no more than once per day. Your doctor will decide the dose that is right for you. In patients taking certain medications such as ritonavir, indinavir, ketoconazole, itraconazole, and erythromycin, lower doses of LEVITRA are recommended, and time between doses of LEVITRA may need to be extended. In clinical trials, the most commonly reported side effects were headache, flushing, and stuffy or runny nose. LEVITRA is available in 2.5-mg, 5-mg, 10-mg, and 20-mg tablets. About Erectile Dysfunction The consistent or recurrent inability of a man to attain and/or maintain a penile erection sufficient for sexual performance1 – is a common health condition among men that is largely untreated. It is estimated that some degree of ED affects more than one half of all men over the age of 402– 152 million men worldwide3 and 30 million men in the United States alone.4 Despite the high prevalence of sexual problems, nine out of 10 men in the U.S. have not yet sought treatment from a physician.5 1. Jardin A, Wagner G, Khoury S, et al. Recommendations of the 1st International Consultation on Erectile Dysfunction. Co-sponsored by the World Health Organization (WHO), International Consultation on Urological Diseases (ICUD) and Societe Internationale d’Urologie (SIU) and held July 1-3, 1999, Paris. 2000, p. 713. 2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61. 3. Aytac IA, McKinlay JB, Krane RI. The likely worldwide increase of erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-56 4. National Institutes of Health, Consensus Development Conference Statement, December 7-9, 1992. Online data: http://odp.od.nih.gov/consensus/cons/091/091_statement.htm. (accessed 8/26/02). 5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544. About Bayer Pharmaceuticals Corporation Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality of life by diagnosing, preventing and treating disease. Forward Looking Statement This news release contains forward-looking statements based on current
assumptions and forecasts made by Bayer Group management. Various known and
unknown risks, uncertainties and other factors could lead to material
differences between the actual future results, financial situation,
development or performance of the company and the estimates given here.
These factors include those discussed in Bayer’s public reports filed with
the Frankfurt Stock Exchange and with the U.S. Securities and Exchange
Commission (including its Form 20-F). Bayer assumes no liability whatsoever
to update these forward-looking statements or to conform them to future
events or developments. About GSK GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information about LEVITRA, please visit www.LEVITRA.com.
|